Engineered ovalbumin-expressing regulatory T cells protect against anaphylaxis in ovalbumin-sensitized mice-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Engineered ovalbumin-expressing regulatory T cells protect against anaphylaxis in ovalbumin-sensitized mice

Published:2019-10 Issue: Volume:207 Page:49-54
ISSN:1521-6616
Container-title:Clinical Immunology
language:en
Short-container-title:Clinical Immunology

Author:

Abdeladhim Maha,Zhang Ai-Hong,Kropp Laura E.,Lindrose Alyssa R.,Venkatesha Shivaprasad H.,Mitre Edward,Scott David W.

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference18 articles.

1. FVIII-specific human chimeric antigen receptor (CAR) T-regulatory cells suppress T-and B-cell responses to FVIII;Yoon;Blood,2017

2. Engineered antigen-specific human regulatory T cells: immunosuppression of FVIII-specific T- and B-cell responses;Kim;Blood,2015

3. Targeting antigen-specific B cells using antigen-expressing transduced regulatory T cells;Zhang;J. Immunol.,2018

4. Engineered FVIII-expressing cytotoxic T cells target and kill FVIII-specific B cells in vitro and in vivo;Parvathaneni;Blood Adv,2018

5. Effect of B-cell depletion using anti-CD20 therapy on inhibitory antibody formation to human FVIII in hemophilia A mice;Zhang;Blood,2011

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A mutation in Themis contributes to anaphylaxis severity following oral peanut challenge in CC027 mice;Journal of Allergy and Clinical Immunology;2024-08

2. T cell function test in food allergy;Encyclopedia of Food Allergy;2024

3. Promises and Pitfalls of Next-Generation Treg Adoptive Immunotherapy;Cancers;2023-12-17

4. Unlocking the potential of Tregs: innovations in CAR technology;Frontiers in Molecular Biosciences;2023-10-12

5. Regulatory T Cell-Targeted Immunomodulatory Therapy for Long-Term Clinical Improvement of Atopic Dermatitis: Hypotheses and Perspectives;Life;2023-08-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3